Your session is about to expire
← Back to Search
Study Summary
This trial seeks to understand the role of leucine in salt-induced hypertension and gut microbiome alteration.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I identify as black or white and am between 18 and 65 years old.I am on medication that affects my blood pressure or gut health.I am between 18 and 65 years old.I have a health condition that affects how my body handles sodium.
- Group 1: Sodium active, HMB placebo
- Group 2: Sodium active, HMB active
- Group 3: Sodium placebo, HMB placebo
- Group 4: Sodium placebo, HMB active
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there still openings available for this research project?
"The trial is still open for enrollment as indicated by clinicaltrials.gov; the research was initially posted on October 1st 2021 and has been recently modified on August 23rd 2022."
Are applicants who are below a certain age eligible for this research project?
"The eligibility parameters for this trial necessitate that the potential participants must be aged between 18 and 65. There are additional 5 clinical trials specifically designed for people under 18, with 82 available to those over 65 years old."
How many participants have been approved for involvement in this research project?
"Affirmative. Details present on clinicaltrials.gov indicate that this trial, which launched on October 1st 2021, is presently conducting participant recruitment. A total of 80 participants from a single location must be enrolled to complete the study."
Who can sign up to take part in these clinical trials?
"This clinical trial is accepting 80 participants aged 18-65 who present with normotensive blood pressure levels (systolic <140 mmHg and diastolic <90mmHg). Additionally, only Black or White individuals may apply."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger